Clinical features, molecular genetics, and pathophysiology of dominant optic atrophy.-Reference-Cited by-同舟云学术

Clinical features, molecular genetics, and pathophysiology of dominant optic atrophy.

Published:1998-10-01 Issue:10 Volume:35 Page:793-800
ISSN:1468-6244
Container-title:Journal of Medical Genetics
language:en
Short-container-title:Journal of Medical Genetics

Author:

Votruba M,Moore A T,Bhattacharya S S

Publisher

BMJ

Subject

Genetics(clinical),Genetics

Reference90 articles.

1. Genetic risks;Lyle, W.M.,1990

2. Dominant optic atrophy mapped to chromosome 3q region. II. Clinical and epidemiological aspects;Kjer, B.; Eiberg, H.; Kjer, P.; Rosenberg, T.;Acta Ophthalmol Scand,1996

3. Infantile optic atrophy with dominant mode of inheritance: a clinical and genetic study of;Kjer, P.;Acta Ophthalmol Scand; Danish families,1959

4. No evidence of genetic heterogeneity in dominant optic atrophy;Bonneau, D.; Souied, E.; Gerber, S.;J Med Genet,1995

5. Genetic refinement of dominant optic atrophy (OPAl) locus to within a 2 cM interval of chromosome 3q. J';Votruba, M.; Moore, A.T.; Bhattacharya, S.S.;Med Genet,1997

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maculopapillary Bundle Degeneration in Optic Neuropathies;Current Neurology and Neuroscience Reports;2024-06-04

2. The Morphology of Normal, Aging, and Glaucomatous Optic Nerves;Reference Module in Neuroscience and Biobehavioral Psychology;2024

3. Idebenone Treatment in Patients with OPA1-Dominant Optic Atrophy: A Prospective Phase 2 Trial;Neuro-Ophthalmology;2023-09-14

4. In Vivo Efficacy and Safety Evaluations of Therapeutic Splicing Correction Using U1 snRNA in the Mouse Retina;Cells;2023-03-21

5. Glaucomatous optic neuropathy: Mitochondrial dynamics, dysfunction and protection in retinal ganglion cells;Progress in Retinal and Eye Research;2022-11